Adhesions of Soft Tissue
Conditions
Keywords
Lumbar pathology, requiring elective lumbar interbody fusion
Brief summary
The objective of this study is to evaluate the clinical effectiveness of AmnioFix™ in the reduction of the tenacity and frequency of soft tissue adhesions during the removal of segmental posterior lumbar instrumentation.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Adults (18 years or older) * Diagnosed with lumbar pathology requiring elective lumbar interbody fusion * Willingness to comply to follow-up examinations and diagnostic imaging procedures * Ability to give full written informed consent
Exclusion criteria
* Previous surgical procedure performed at same site * Sign or symptoms of other disease which could result in allograft failure * Require a corpectomy * Participating in another drug or device clinical trial * Pregnant or may become pregnant during the study * Prisoner * Involved in workmen's compensation or other litigation relative to a spine injury * Past medical history of allograft implantation which resulted in graft failure * Any condition requiring treatment above the normal standard of care * Currently taking medications which could affect graft incorporation (supervising physicians discretion) * Auto-Immune disease * Renal failure * Failure to sign or understand informed consent information * History of drug and/or alcohol abuse * Allergic to aminoglycosides
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tenacity and frequency of soft tissue adhesion | At the time of removal of segmental posterior lumbar instrumentation |
Secondary
| Measure | Time frame |
|---|---|
| Presence and extent of scar tissue using histological analysis of the lumbar tissue adjacent to the surgical site | At the time of removal of segmental posterior lumbar instrumentation |
| Number of intra-operative complications | At the time of removal of segmental posterior lumbar instrumentation |
Countries
United States